PCARTBI Stock Latest News
Private CompaniesARTBIO Highlights Prostate Cancer Awareness Effort1w agoARTBI
Private CompaniesRadiopharmaceutical Therapy Trends Highlighted at EANM by ARTBIO3w agoARTBI
Private CompaniesARTBIO Highlights Engagement With Oncology Innovation at ESMO Congress3w agoARTBI
Private CompaniesARTBIO Highlights Presence at Major European Nuclear Medicine Conference1M agoARTBI
Private CompaniesARTBIO Highlights Prostate Cancer Burden and Radioligand Therapy Opportunity1M agoARTBI
Private CompaniesARTBIO Strengthens Radiopharmaceutical Development Team With Senior Hire2M agoARTBIPrivate CompaniesARTBIO Highlights Alpha Radioligand Therapy Pipeline and Collaboration Efforts3M agoARTBI
Private CompaniesARTBIO Emphasizes Dosimetry Focus in Upcoming Radiopharmaceutical Therapy Presentation4M agoARTBI
Private CompaniesARTBIO – Weekly Recap4M agoARTBI
Private CompaniesRadiopharmaceutical Strategy Emphasizes Alpha Radioligand Therapy Focus5M agoARTBI
Private CompaniesARTBIO Emphasizes Health Awareness and Inclusion Initiatives5M agoARTBI
Private CompaniesARTBIO – Weekly Recap5M agoARTBIPrivate CompaniesARTBIO Emphasizes Internal Research Talent in PSMA-Targeting Radioligand Development5M agoARTBI
Private CompaniesARTBIO Highlights Participation in 2026 Nuclear Medicine Industry Meeting5M agoARTBI
Private CompaniesARTBIO Plans Engagement at Major 2026 Nuclear Medicine Meeting5M agoARTBI
Private CompaniesARTBIO Signals Strategic Focus on Radioligand Therapy at ASCO Oncology Meeting5M agoARTBI
Private CompaniesARTBIO Engages With Radioligand Therapy Developments at ASCO Oncology Meeting5M agoARTBI
Private CompaniesARTBIO – Weekly Recap6M agoARTBIPrivate CompaniesARTBIO Strengthens Nuclear Metrology Expertise With Senior Leadership Hire6M agoARTBI




